(Q40275515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Qiao J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Moreno J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sanchez-Perez L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kottke T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Thompson J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Diaz RM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Vile R

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

25 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1457-1470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302782

28 January 2020

exact match

0 references

cites work

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Replicative retroviral vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

RD114-pseudotyped retroviral vectors kill cancer cells by syncytium formation and enhance the cytotoxic effect of the TK/GCV gene therapy strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Immune response to green fluorescent protein: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Murine leukemia virus (MLV) replication monitored with fluorescent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Success for gene therapy: render unto Caesar that which is Caesar's

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Lack of superinfection interference in retroviral vector producer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

High-titer packaging cells producing recombinant retroviruses resistant to human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302782

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724095%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 January 2020

1018919340

0 references

1 reference